Outcomes In our analysis, ivabradine showed a numerical trend toward lower all-cause mortality compared to metoprolol, with a pooled odds ratio of 0.52 (95%CI: 0.17-1.64; P = 0.27), although this difference did not reach statistical significance.
← all excerpts
Efficacy of ivabradine in heart rate reduction after cardiac transplantation: Systematic review and meta-analysis.
1
0.2700
0.2700